ClinicalTrials.Veeva

Menu

Enhanced Recovery After Laparoscopic Colorectal Surgery Study

V

Vilnius University

Status

Unknown

Conditions

Laparoscopic Colorectal Surgery

Treatments

Other: Type of anaesthesia

Study type

Interventional

Funder types

Other

Identifiers

NCT04091815
19BMT32

Details and patient eligibility

About

The study will assess the impact on quality of care after implementation of the ERAS (Enhanced Recovery After Surgery) protocol for laparoscopic colorectal surgery in Vilnius University Hospital Santaros klinikos. The primary goal of this study is to compare efficacy of two different types of anaesthesia - general and combined (spinal and general), efficacy of multimodal analgesia in both groups, need for rescue analgetics, time to bowel movement, time to ambulation. We also aim to study overall patient satisfaction and measure health-related quality of life, from date of randomisation until the date of hospital discharge, 30 days, 3 months and 6 months post-discharge.

Full description

Recovery After Surgery (ERAS) protocol is a multimodal perioperative care pathway designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery, now widely accepted in laparoscopic colorectal surgery.

In laparoscopic colorectal surgery, the ERAS protocol involves an accurate interview with the patient in the preoperative phase aimed at smoking and alcohol cessation, the reduction of preoperative fasting with administration of oral carbohydrates before surgery, use of intestinal preparation for selected cases only, the prophylaxis of thromboembolism, a correct antibiotic prophylaxis, the prevention of intraoperative hypothermia and hypotension, prevention of volume overload, preference for minimally invasive surgery, multimodal analgesia with reduced opioid requirements, local anaesthetics for wound infiltration, prevention of postoperative nausea and vomiting, very limited use of the nasogastric tube, early removal of the urinary catheter, multimodal analgesia to minimize opiate consumption, early postoperative mobilization and early postoperative feeding, to promote rapid recovery of gastrointestinal functions.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age and older.
  • scheduled for laparoscopic colorectal surgery.
  • patient informed and having accepted the principle of enhanced recovery after surgery.
  • patient written consent will be obtained preoperatively for eligible study participants.

Exclusion criteria

Preoperative:

  • patients who can not comply with the ERAS protocol because they do not understand the language or has a cognitive disorder.
  • patients with a documented allergy to nonsteroidal anti-inflammatory drugs and acetaminophen.
  • preoperative renal insufficiency (creatinine clearance less than or equal to 30ml/min) or hemodialysis.
  • patients with a history of hepatic impairment.
  • chronic pain condition that required daily opioid dependence.

Operative:

  • conversion to laparotomy.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

I group - general anaesthesia
Active Comparator group
Description:
General anesthesia, induction with fentanyl, propofol, roqurium. Maintenance - sevoflurane (BIS ranges 40 - 60), opioids (fentanyl and morphine), roqurium. Intraoperative fluid administration - 2000ml sterofundine, 500ml Gelaspan. 75mg intravenous diclofenac sodium on anesthesia induction, 1000mg intravenous acetaminophen at the start of wound closure. Surgical site infiltration, bupivacaine, 0.25%-10 ml, after the last suture.
Treatment:
Other: Type of anaesthesia
II group - combined - spinal and general anaesthesia
Experimental group
Description:
Spinal anesthesia: L3-4 interspace, 27G needle, bupivacaine hyperbaric, 16 mg, morphine sulfate 0.1% - 0.1ml. General anesthesia, induction with fentanyl, propofol, roqurium. Maintenance - sevoflurane (BIS ranges 40 - 60), roqurium. Intraoperative fluid administration - 2000ml sterofundine, 500ml Gelaspan. 75mg intravenous diclofenac sodium on anesthesia induction, 1000mg intravenous acetaminophen at the start of wound closure. Surgical site infiltration, bupivacaine, 0.25%-10 ml, after the last suture.
Treatment:
Other: Type of anaesthesia

Trial contacts and locations

1

Loading...

Central trial contact

Egle Kontrimaviciute, MD, PhD; Agne Jankuviene, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems